# Besivance

NDC: 82260-466
Generic name: Besifloxacin
Labeler / Manufacturer: Bausch & Lomb Americas Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: SUSPENSION
Routes: OPHTHALMIC
Marketing started: 20260109

FDA application: NDA022308

## Active ingredients

- BESIFLOXACIN: 6 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"82260-466"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=82260-466
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ff971287-5610-4f15-8392-fc974e6ff646